Ken Griffin
CELZ icon

Ken Griffin’s Creative Medical Technology CELZ Stock Holding History

Ken Griffin’s Portfolio CELZ Stock Details CELZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-17,460
Closed -$34.2K – 13091
2025
Q4 		$34.2K Buy
+17,460
New +$51.6K ﹤0.01% 12182
2025
Q3 		– Sell
-11,145
Closed -$29.5K – 12865
2025
Q2 		$29.5K Buy
+11,145
New +$24K ﹤0.01% 11985
2022
Q4 		– Sell
-25,787
Closed -$113K – 14899
2022
Q3 		$113K Buy
+25,787
New +$175K ﹤0.01% 10986

Other funds holding CELZ

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Ken Griffin's CELZ Position: Q1 2026 in Review

Ken Griffin sold out of Creative Medical Technology (CELZ) in Q1 2026, closing a stake of 17,460 shares — an estimated $34.2K sold.

Ken Griffin first reported a position in CELZ in Q3 2022 and held it in 3 quarters. The position peaked at $113K in Q3 2022. 11 funds tracked by Wall St. Rank hold CELZ as of Q1 2026.

  • Ken Griffin reported no remaining Creative Medical Technology position as of Q1 2026 after selling out during the quarter.
  • Ken Griffin sold 17,460 Creative Medical Technology shares in Q1 2026, an estimated $34.2K.
  • Ken Griffin first reported a position in Creative Medical Technology in Q3 2022 and held it in 3 quarters.
  • Ken Griffin's Creative Medical Technology position peaked at $113K in Q3 2022.
  • 11 funds tracked by Wall St. Rank held Creative Medical Technology as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.